Vaccines, blood, antisera, toxins and cultures in   Indonesia

Exports In 2023, Indonesia exported $169M in Vaccines, blood, antisera, toxins and cultures, making it the 36th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 191st most exported product in Indonesia. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Indonesia are: India ($75.2M), Pakistan ($23.7M), Nigeria ($11.9M), South Africa ($4.74M), and Vietnam ($4.53M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Indonesia between 2022 and 2023 were Pakistan ($13M), India ($5.58M), and Switzerland ($3.07M).

Imports In 2023, Indonesia imported $378M in Vaccines, blood, antisera, toxins and cultures, becoming the 55th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 126th most imported product in Indonesia. Indonesia imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($93.7M), India ($51.2M), France ($35.7M), Belgium ($34.9M), and Germany ($27.8M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Indonesia between 2022 and 2023 were Austria ($3.75M), Singapore ($2.33M), and Ireland ($1.76M).